We found that the effect of inhibiting PI3K/AKT was basically the same as that of directly inhibiting CCL25/CCR9, implying that CCL25/CCR9 can regulate the expression of the EMT-related transcription factor SLUG through the PI3K/AKT signaling pathway, which results were consistent with tumor cells experiments. The gene discussed is CCL25; the disease is neoplasm.